|
1）Volta M, Milnerwood AJ, Farrer MJ. Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinsonʼs disease. Lancet Neurol. 2015; 14: 1054-64
|
|
|
|
2）Funayama M, Ohe K, Amo T, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinsonʼs disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015; 14: 274-82
|
|
|
|
|
|
3）Bras J, Guerreiro R, Hardy J. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci. 2012; 13: 453-64
|
|
|
|
|
|
4）Longen S, Bien M, Bihlmaier K, et al. Systematic analysis of the twin cx(9)c protein family. J Mol Biol. 2009; 393: 356-68
|
|
|
|
|
|
5）Liu Z, Guo J, Li K, et al. Mutation analysis of CHCHD2 gene in Chinese familial Parkinsonʼs disease. Neurobiol Aging. 2015; 36: 3117. e7-8
|
|
|
|
|
|
6）Jansen IE, Bras JM, Lesage S, et al. CHCHD2 and Parkinsonʼs disease. Lancet Neurol. 2015; 14: 678-9
|
|
|
|
|
|
7）Vilariño-Güell C, Wider C, Ross OA, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011; 89: 162-7
|
|
|
|
|
|
8）Ando M, Funayama M, Li Y, et al. VPS35 mutation in Japanese patients with typical Parkinsonʼs disease. Mov Disord. 2012; 27: 1413-7
|
|
|
|
|
|
9）Miura E, Hasegawa T, Konno M, et al. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinsonʼs disease. Neurobiol Dis. 2014; 71: 1-13
|
|
|
|
|
|
10）Tang FL, Liu W, Hu JX, et al. VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function. Cell Rep. 2015; 12: 1631-43
|
|
|
|
|
|
11）Vilarino-Guell C, Rajput A, Milnerwood AJ, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet. 2014; 23: 1794-801
|
|
|
|
|
|
12）Saitsu H, Nishimura T, Muramatsu K, et al. De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet. 2013; 45: 445-9, 9e1
|
|
|
|
|
|
13）Dusi S, Valletta L, Haack TB, et al. Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2014; 94: 11-22
|
|
|
|
|
|
14）Nishioka K, Oyama G, Yoshino H, et al. High frequency of beta-propeller protein-associated neurodegeneration(BPAN)among patients with intellectual disability and young-onset parkinsonism. Neurobiol Aging. 2015; 36: 2004 e9- e15
|
|
|
|
|
|
15）Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med. 2002; 32: 833-40
|
|
|
|
|